Welcome to our dedicated page for Elite Health Systems SEC filings (Ticker: EHSI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Elite Health Systems's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Elite Health Systems's regulatory disclosures and financial reporting.
Elite Health Systems Inc. (EHSI) reported its first meaningful operating revenues as it launched Medicare Advantage plans and consolidated Physician Support Systems (PSS), but results remain deeply loss-making with liquidity pressure. For the six months ended June 30, 2026, revenue was $2.7 million (all from services and policy revenue, versus zero a year earlier), while the net loss widened to $2.8 million from $0.9 million.
Total assets fell to $3.9 million from $6.7 million at December 31, 2025, and cash declined to $1.3 million from $3.8 million. Working capital dropped to $0.5 million, and accumulated deficit increased to $15.1 million. Management states that these factors raised substantial doubt about the company’s ability to continue as a going concern, although it points to roughly $14 million previously raised and believes additional capital is accessible.
The board has authorized a strategic review that may include new equity or debt, asset sales, or a merger or disposition of all assets, with no set timetable. After quarter-end, EHSI entered into a $525,000 subordinated note with its CEO at 10% interest, paired with warrants for 110,526 shares at $0.95, and may accept up to $1.5 million on the same terms.
Elite Health Systems Inc. filed a notification that it will delay submitting its Form 10-Q for the fiscal quarter ended June 30, 2026. The company cites complex accounting related to the commencement of its Medicare Advantage insurance operations, which has prevented completion of all processes and procedures within the normal deadline without unreasonable effort or expense.
The company states it expects to file the Form 10-Q on or before August 19, 2026. The upcoming quarterly period will include revenue and medical expense from its Medicare Advantage operations, as well as contributions from Physician Support Services Inc, which was acquired in November 2025.
Elite Health Systems Inc. entered into a financing with its CEO, Dr. Prasad Jeereddi, consisting of a $525,000 subordinated note and an accompanying warrant. The note is unsecured, bears 10% annual interest, includes a 2% prepayment penalty, and matures on July 31, 2027.
The warrant allows Dr. Jeereddi to purchase up to 110,526 shares of common stock at $0.95 per share, exercisable in whole or part through July 31, 2031, including on a cashless basis if the shares are not then registered. These warrant shares are currently unregistered and subject to transfer restrictions. The agreement permits additional investment on the same terms up to an aggregate of $1.5 million.
Elite Health Systems Inc. reported that CEO and 10% owner Jeereddi Prasad Anjaneya received a grant of 110,526 common stock warrants on July 31, 2026, with a $0.95 per-share exercise price and a July 31, 2031 expiration. Following this grant, he holds 3,624,484 common shares directly, 225,716 common shares indirectly through an entity, and the granted warrants.
Elite Health Systems Inc. reports that its Board of Directors has authorized management to review, consider and pursue strategic alternatives for the company. Options under review include raising equity or debt capital, selling certain assets or operating businesses, or engaging in other strategic financings or transactions such as a merger or a disposition of all of its assets.
The company notes there is no timetable for completing any transaction and there is no assurance any strategic transaction will be completed or will increase stockholder value. The Board may terminate the review at any time. Elite Health Systems states that failure to consummate a strategic transaction, including a financing, merger, sale or disposition of all or substantially all assets, or other alternative, could have a material adverse effect on its liquidity, financial condition and ability to continue operations, while it continues to operate in the ordinary course and focus on its Medicare Advantage business.
Elite Health Systems Inc. CEO and director Jeereddi Prasad Anjaneya reported an open-market purchase of common stock. On this Form 4, he bought 42,105 shares of Elite Health Systems common stock at $0.95 per share, classified as a direct holding. After this transaction, he directly owns 3,624,484 common shares. A separate entry reports 225,716 common shares held indirectly through an entity for which he is a managing member and major equity owner, giving investors a view of both his direct and indirect equity exposure.
Elite Health Systems Inc. CEO Jeereddi Prasad Anjaneya reported two open-market purchases of the company’s Common Stock through an affiliated entity, Haven Hospital LLC. The transactions totaled 12,000 shares at a price of $1.05 per share.
Each purchase involved 6,000 shares, executed on May 15 and June 1, 2026. Following these indirect acquisitions by Haven Hospital LLC, the reporting person’s indirect holdings increased to 239,423 shares of Common Stock.
Elite Health Systems Inc. reported a larger loss as it ramped up its new Medicare Advantage and healthcare services platform in the quarter ended March 31, 2026. Revenue was $1.4 million, primarily from related-party services at Physician Support Systems, while net loss widened to $1.3 million from $0.4 million a year earlier.
Total assets fell to $5.4 million, including cash of $2.6 million, and stockholders’ equity declined to $4.1 million as the accumulated deficit reached $13.5 million. Management disclosed that recurring losses, limited cash and no credit facility raised substantial doubt about the company’s ability to continue as a going concern, though it has raised about $14 million in equity to date and expects to seek more capital in 2026.
Elite Health has obtained a Knox-Keene license and Centers for Medicare & Medicaid Services approval to operate Medicare Advantage plans in several California counties and began plan operations on January 1, 2026. It also completed the acquisition of Physician Support Systems, Inc. in late 2025, recording goodwill of $4.96 million and later recognizing a $3.98 million goodwill impairment.
Elite Health Systems Inc. submitted a Form 12b-25 notifying the SEC that its Form 10-Q for the quarter ended March 31, 2026 will be filed late. The company says accounting for the commencement of its Medicare Advantage insurance operations is complex and requires additional time. The registrant will file the Form 10-Q on or before May 20, 2026.
Elite Health Systems Inc. director and CEO Jeereddi Prasad Anjaneya reported an indirect open-market purchase of 1,707 shares of Common Stock at $1.08 per share on April 29, 2026. After this transaction, the indirectly held position through Haven Hospital LLC totaled 227,423 shares.